AMM 314: Botox Now Targets Neck Bands: Aesthetic Game-Changer!
January 03, 2025
This episode provides updates on Botox® Cosmetic’s expanded FDA approval, now including treatment for platysmal bands. Dr. Alexander Rivkin, an expert in non-surgical aesthetics, discusses his role in the study and the implications of this advancement for non-surgical rejuvenation options. Liste expects insights into minimally invasive treatments and the future of aesthetic medicine, with a focus on achieving natural results.
Quick Takes
- Botox® Cosmetic now covers four aesthetic indications: frown lines, forehead lines, crow’s feet, and platysmal bands.
- Dr. Alexander Rivkin, a facial cosmetic specialist, played a key role in the Botox® study for platysmal bands.
- Dr. Rivkin’s innovative techniques and expertise in facial and neck anatomy offer natural and exceptional results at Westside Aesthetics in Los Angeles.
Episode Transcript
Today is January 3rd, 2025, and we’re diving into a significant update from the world of aesthetic medicine. Botox® Cosmetic has now extended its FDA approval to cover four aesthetic indications, including frown lines, forehead lines, crow’s feet, and now, platysmal bands.
At the forefront of this advancement is Dr. Alexander Rivkin, a Yale-trained facial cosmetic specialist who has been a leading figure in non-surgical aesthetics for over 15 years. Dr. Rivkin was a principal investigator in the Botox® study for platysmal bands, a common concern for those seeking a rejuvenated neck appearance without surgery. This approval means a broader portfolio of non-surgical options for patients, emphasizing minimally invasive treatments.
Dr. Rivkin’s expertise in facial and neck anatomy and his innovative techniques ensure exceptional and natural results. As the founder of Westside Aesthetics in Los Angeles, he remains committed to education and clinical excellence, shaping the future of aesthetic medicine. This is a pivotal moment for those looking to enhance their aesthetic options safely and effectively.